1.The effect of polyethylene terephthalates coated with 58S bioactive glass on graft-bone healing
Yang WU ; Shiyi CHEN ; Jia JIANG ; Hong LI ; Kai GAO
Chinese Journal of Orthopaedics 2012;32(6):576-581
Objective To observe the effect of polyethylene terephthalates (PET) coated with 58S bioactive glass on graft-bone healing.Methods The PET coated with 58S bioactive glass was used in experimental group,and uncoated PET was used as a control.The coating solution was made of 20% bioactive glass powder and 80% gelatin powder (by weight).In our vitro study,4×104/ml MT3T3-E1 cells were cultured in 24-well plates with the coated or uncoated PET,and the MTT and ALP were tested at 1,3,5 days to show the proliferation and the activity of the cells.The SEM and the X-ray photoelectron spectrometer were adopted to analyze the surface characteristics of the fiber.In our vivo study,24 skeletally mature New Zealand white rabbits were randomly divided into two groups,the 58S-PET group and the PET group.Both groups underwent a surgical procedure to establish a tibia-articular tendon-bone healing model.Mechanical examination and histological assay were taken to verify the coating effect in vivo.Results The 58S-PET group showed significantly differences in both the MTT and ALP tests at each time point (3,5 days) compared with the PET group.In the animal experiments,the maximum load increased by time in both groups.At 6 weeks,the load-to-failure was significantly higher in the 58S-PET group [(61.70±6.95) N]than that of the PET group [(45.21±9.78) N].At 12 weeks,the load-to-failure was also significantly higher in the 58S-PET group [(89.25±9.50) N]than that of the PET group [(71.38±6.26) N].In the histological assay,it was found that there was new bone formation in the indistinct interface between the graft and the host bone in both groups at 6,12 weeks,and a stronger binding was seen in the 58S-PET group than in the PET group.Conclusion The 58S-PET could enhance the proliferation and activity of the osteoblast and therefore promote the new bone formation and subsequently leads to a positive effect on tendon-bone healing.
2.Clinical Observation of Acupuncture plus Rehabilitation for Lower-limb Dysfunction Due to Different Types of Ataxia After Stroke
Hai LU ; Weijing BAI ; Huijing MA ; Miao ZHANG ; Shiyi GAO ; Haomin LIU ; Chunhong ZHANG ; Lianzhong. WU
Shanghai Journal of Acupuncture and Moxibustion 2017;36(4):374-378
Objective To observe the clinical efficacy ofXing Nao Kai Qiao(brain-awakening orifice-opening) needling method plus Frenkel's balance rehabilitation exercise in treating lower-limb dysfunction due to different types of ataxia after stroke.MethodA total of 115 eligible patients were randomized into two groups. Fifty-seven cases in the treatment group were intervened by Xing Nao Kai Qiaoneedling plus rehabilitation training; 58 cases in the control group were intervened byXing Nao Kai Qiaoneedling method alone. Berg Balance Scale (BBS) was adopted to evaluate the symptoms, balance function, and therapeutic efficacy before and after the treatment.Result In the treatment group, the markedly effective rate was respectively 72.2%, 83.3% and 61.1% in the cerebella subtype, brainstem subtype and basal ganglia subtype, and the total effectiverate was respectively 100.0%, 94.4% and 94.4%; in the control group, the markedly effective rate was respectively 21.1%, 35.0% and 58.8%, and the total effective rate was respectively 94.7%, 85.0% and 82.4%, and the between-group differences were statistically significant (P<0.05). After the treatment, the BBS score showed significant intra-group differences in both groups (P<0.01); the between-group comparisons showed that there were significant differences in comparing the scores of cerebella and brainstem subtypes after the treatment (P<0.05).ConclusionXing Nao Kai Qiaoneedling method plus Frenkel's rehabilitation exercise can effectively improve the symptoms of poststroke lower-limb ataxia, especially for cerebella and brainstem subtypes.
3.Development of Mobile Medical Consumable Material Management System.
Zheng GAO ; Hao XU ; Shiyi ZHANG
Chinese Journal of Medical Instrumentation 2018;42(1):38-40
The operation of traditional medical consumables management system depends on computer and network. The consumable material manager can't manage the consumable in time. In order to meet the convenience, flexibility, timeliness in materials management, this paper designs a mobile medical consumables management system based on Android platform and WeChat Official Accounts. The system helps the hospital manage medical consumable materials more conveniently and efficiently.
Equipment and Supplies
;
Humans
;
Mobile Applications
4.Formation, reconstruction and prospect of pulmonary and critical care medicine in China
Yuqing WANG ; Cunbo JIA ; Ting YANG ; Shiyi GAO ; Chen WANG
Chinese Journal of Hospital Administration 2023;39(7):504-509
The development of respiratory and critical care medicine from a combination and binding approach to a cross-integrated reconstruction of pulmonary and critical care medicine (PCCM) has become an inevitable trend and basic strategy for the high-quality development of respiratory medicine and actively responding to the prevention and control of major disease risks in China. The author analyzed the dilemmas and bottlenecks in the long-term development of traditional respiratory medicine in China and their causes, summarized the international experience in the establishment of modern respiratory disciplines, and systematically reviewed the development process of traditional respiratory disciplines in China to PCCM department.Finally, the author pointedly put forward some thoughts and prospects on leading the development of disciplines from personnel training, department construction and industry development, promoting the new business form of " integrated vertical and horizontal" disciplines with intelligent information construction, and practicing the concept of population medicine to improve the high-quality development of PCCM.
5.Correlation between insulin resistance and coronary collateral circulation in patients with chronic total coronary occlusion
Sigan HU ; Zengwei CHENG ; Min LI ; Shiyi GAO ; Dasheng GAO ; Pinfang KANG
Journal of Southern Medical University 2024;44(4):780-786
Objective To explore the impact of diabetes on collateral circulation (CC) development in patients with chronic total coronary occlusion (CTO) and the underlying regulatory mechanism. Methods This study was conducted among 87 patients with coronary heart disease (CHD), who had CTO in at least one vessel as confirmed by coronary angiography. Among them 42 patients were found to have a low CC level (Cohen-Rentrop grades 0-1) and 45 had a high CC level (grades 2-3). In the 39 patients with comorbid diabetes mellitus and 48 non-diabetic patients, insulin resistance (IR) levels were compared between the subgroups with different CC levels. The steady-state mode evaluation method was employed for calculating the homeostatic model assessment for insulin resistance index (HOMA-IR) using a mathematical model. During the interventional procedures, collateral and peripheral blood samples were collected from 22 patients for comparison of the metabolites using non-targeted metabolomics analysis. Results NT-proBNP levels and LVEF differed significantly between the patients with different CC levels (P<0.05). In non-diabetic patients, HOMA-IR was higher in low CC level group than in high CC level groups. Compared with the non-diabetic patients, the diabetic patients showed 63 upregulated and 48 downregulated metabolites in the collateral blood and 23 upregulated and 14 downregulated metabolites in the peripheral blood. The differential metabolites in the collateral blood were involved in aromatic compound degradation, fatty acid biosynthesis, and steroid degradation pathways; those in the peripheral blood were related with pentose phosphate metabolism, bacterial chemotaxis, hexanoyl-CoA degradation, glycerophospholipid metabolism, and lysine degradation pathways. Conclusion The non-diabetic patients with a low level of CC had significant insulin resistance. The degradation pathways of aromatic compounds, fatty acid biosynthesis, and steroid degradation are closely correlated with the development of CC.
6.Design and practice of standardized construction project for pulmonary and critical care medical departments in China
Cunbo JIA ; Yuqing WANG ; Nan LUO ; Zhongguang YU ; Qian GAO ; Ting YANG ; Shiyi GAO ; Lingyu GE ; Chen WANG
Chinese Journal of Hospital Administration 2023;39(7):510-514
The incidence and prevention of chronic non-communicable respiratory diseases represented by chronic obstructive pulmonary disease, bronchial asthma, and lung cancer, as well asrespiratory communicable diseases such as viral pneumonia and tuberculosis, are becoming increasingly severe and complex.Only by constructing the modern respiratory discipline system of pulmonary and critical care medicine (PCCM) and developing the standardized management of PCCM departments in the hospital, could we achieve the goal of establishing overall specialized capacity for respiratory diseases and improving the ability of disease prevention and treatment in China. This article introducedthe project design and practice exploration based on the standardized construction of PCCM department in hospital, in the context of the new pattern of modern respiratory discipline.It focused on project initiation and management, formulation of evaluation standards, identification process and grading, and phased effectiveness.It also discussed and analyzed the experience, enlightenment, existing problems and suggestions, which could provide reference and advance experience for innovation, governance and improvement of capacity building of respiratory specialty and high-quality development of other medical disciplines and specialties in China.
7.Correlation between insulin resistance and coronary collateral circulation in patients with chronic total coronary occlusion
Sigan HU ; Zengwei CHENG ; Min LI ; Shiyi GAO ; Dasheng GAO ; Pinfang KANG
Journal of Southern Medical University 2024;44(4):780-786
Objective To explore the impact of diabetes on collateral circulation (CC) development in patients with chronic total coronary occlusion (CTO) and the underlying regulatory mechanism. Methods This study was conducted among 87 patients with coronary heart disease (CHD), who had CTO in at least one vessel as confirmed by coronary angiography. Among them 42 patients were found to have a low CC level (Cohen-Rentrop grades 0-1) and 45 had a high CC level (grades 2-3). In the 39 patients with comorbid diabetes mellitus and 48 non-diabetic patients, insulin resistance (IR) levels were compared between the subgroups with different CC levels. The steady-state mode evaluation method was employed for calculating the homeostatic model assessment for insulin resistance index (HOMA-IR) using a mathematical model. During the interventional procedures, collateral and peripheral blood samples were collected from 22 patients for comparison of the metabolites using non-targeted metabolomics analysis. Results NT-proBNP levels and LVEF differed significantly between the patients with different CC levels (P<0.05). In non-diabetic patients, HOMA-IR was higher in low CC level group than in high CC level groups. Compared with the non-diabetic patients, the diabetic patients showed 63 upregulated and 48 downregulated metabolites in the collateral blood and 23 upregulated and 14 downregulated metabolites in the peripheral blood. The differential metabolites in the collateral blood were involved in aromatic compound degradation, fatty acid biosynthesis, and steroid degradation pathways; those in the peripheral blood were related with pentose phosphate metabolism, bacterial chemotaxis, hexanoyl-CoA degradation, glycerophospholipid metabolism, and lysine degradation pathways. Conclusion The non-diabetic patients with a low level of CC had significant insulin resistance. The degradation pathways of aromatic compounds, fatty acid biosynthesis, and steroid degradation are closely correlated with the development of CC.
8.Application of two-stage crestal approach sinus elevation in severe atrophic posterior maxilla
Xi LIN ; Zhen ZHOU ; Shaobing LI ; Yan GAO ; Shiyi LI ; Peijun ZHU ; Shulan XU
Chinese Journal of Stomatology 2020;55(11):871-877
Objective:To investigate the feasibility of two-stage crestal approach sinus elevation in severe atrophic maxilla.Methods:A total of 25 patients (male: 13 cases,female: 12 cases) who attended Department of Implant Center, Stomatological Hospital, Southern Medical University from May 2016 to May 2018 were included in this study. The age of the patients was 32-49 years old. The inclusion criteria were: single or multiple tooth loss in posterior maxilla with residual bone height ranged from 1.5 to 3.0 mm and vertical bone width≥6 mm, no pathological changes or septum were detected in the sinus. The elevated sides were divided into three groups according to different buccal-palatal sinus width (SW): wide (16 case, SW>15 mm), normal (12 case, 12 mm≤SW≤15 mm), narrow (5 case, SW<12 mm). Finally, 23 patients with 33 implants were placed by the two-stage crestal approach for sinus elevation. Six months after implant placement, final restorations were delivered. Implant survival rate, implant stability quotient (ISQ), immediate vertical bone height (VBH) after surgeries, changes of sinus elevation height (cSEH), marginal bone loss (MBL) at 1 year follow-up were examined.Results:Twenty-three patients were finally included in the study, including 12 males and 11 females, aged (41.2±7.6) years old. All implants healed uneventfully. ISQ (wide: 50.81±2.69; normal: 60.58±2.54; narrow: 63.12±3.58), immediate VBH after 1st surgery [wide: (7.99±1.13) mm; normal: (8.95±0.81) mm; narrow: (9.18±0.90) mm] and 2nd surgery [wide: (11.46±0.88) mm; normal: (12.77±0.49) mm; narrow: (12.57±0.55) mm], cSEH six months after 1st [wide: (3.87±0.43) mm; normal: (2.01±0.65) mm; narrow: (1.49±0.33) mm] and 2nd [wide: (1.16±0.29) mm; normal: (1.04±0.33) mm ; narrow: (0.97±0.41) mm] surgery, MBL [wide: (0.91±0.05) mm; normal: (0.79±0.10) mm; narrow: (0.74±0.07) mm] were significantly different among three groups ( P<0.05). In all the three groups, cSEH was barely detected at 1-year follow-up ( P>0.05). Conclusions:Two-stage crestal approach for sinus elevation might be an alternative protocol in severe atrophic posterior maxilla, especially in cases with narrow and normal buccal-palatal width. There is an urgent need for long time follow-up and more clinical cases.
9.Active response to population aging with scientific and technological innovation in China
Pengjun ZHANG ; Boya PENG ; Shiyi GAO ; Miao XU ; Mengyao REN ; Bi ZHANG
Chinese Journal of Geriatrics 2022;41(12):1410-1413
The situation of population aging is grim.And scientific and technological innovation is an important strategic support means to solve the problem of population aging.President Xi Jinping has put forward the guiding ideology of "Four Facing" of scientific and technological innovation, pointing out the direction of using science and technology to support the high-quality development of the aging cause and to realize healthy aging.The scientific and technological innovation of population aging has always been highly integrated with exploring international science frontiers, serving main economic sectors, meeting major national needs and safeguarding people's life and health.This paper elaborates on the deep integration between the aging population and the "four facing" of scientific and technological innovation, in order to better construct a new development pattern, and for science to help actively cope with the smooth implementation of the national strategy of population aging.
10.A Prospective Cohort Study on the Risk of Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention with Blood-invigorating and Stasis-dissolving Medicinals
Lintong YU ; Shiyi TAO ; Xiaojuan MA ; Jie GAO ; Hua QYU ; Yu YANG ; Bingchang CHEN ; Dazhuo SHI
Journal of Traditional Chinese Medicine 2024;65(18):1895-1902
ObjectiveTo explore the impact of blood-invigorating and stasis-dissolving medicinals combined with conventional western medicine on the major adverse cardiovascular events (MACE) in patients with coronary heart disease (CHD) after percutaneous coronary intervention (PCI). MethodsA prospective cohort study was conducted to collect data on consecutive cases of CHD after PCI. According to whether blood-invigorating and stasis-dissolving medicinals were used, the cases were divided into a Chinese herbal medicinals (CHM) group and control group. The primary outcome was the incidence of MACE one year after PCI, while the secondary outcomes included TCM syndrome score and echocardiography left ventricular ejection fraction (LVEF). Logistic regression analysis was performed to explore the influencing factors of MACE. ResultsA total of 844 patients who met the criteria were included, with 617 in the CHM group and 227 in the control group. The main blood-invigorating and stasis-dissolving medicinals being used were Danshen (Radix et Rhizoma Salviae Miltiorrhizae, 46.35%), Chuanxiong (Rhizoma Chuanxiong, 45.87%), and Chishao (Radix Paeoniae Rubra, 42.30%). After a median follow-up of 12.73 months, the incidence of MACE in the CHM group (142/617, 23.01%) was significantly lower than that in the control group (68/227, 29.96%) with significant difference (OR=0.70, 95%CI 0.50 to 0.98, P = 0.04). The LVEF of the CHM group [(60.06±6.13)%] was higher than that of the control group [(58.27±7.36)%] with significant difference (t = 0.356, P<0.01). The TCM syndrome score in the CHM group decreased to 12.66±4.47, while that in the control group increased to 13.81±3.88, with the results favoring the CHM group (t = 2.78, P<0.01). Univariate analysis showed correlations between the incidence of MACE after PCI and the use of blood-invigorating and stasis-dissolving medicinals, LVEF, usage of renin-angiotensin-aldosterone system (RAAS) inhibitors, TCM syndrome score, and usage of β blockers (P<0.05). Multivariate analysis showed that the use of blood-invigorating and stasis-dissolving medicinals was significantly associated with the reduction of MACE (P<0.01), while the baseline LVEF decline, TCM syndrome score increase, no use of RAAS inhibitors or β blockers were the risk factors of MACE after PCI (P<0.05). ConclusionThe use of blood-invigorating and stasis-dissolving medicinals based on the conventional western medicine can reduce the risk of MACE one year after PCI of CHD, improve the TCM syndromes and protect heart function.